Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Candidate stroke gene identified:

This article was originally published in Clinica

Executive Summary

A US team has discovered that a genetic variation of the G-protein beta3 (GNbeta3) gene, which has already been linked with hypertension, could increase the risk of stroke in white people. Researchers found that the GNbeta3 825C/T form of the gene was associated with a 1.5 times increased risk of stroke. This association was independent of blood pressure levels and hypertension status, Eric Boerwinkle from the Human Genetics Center at the University of Health Science Center in Houston reports in Stroke (April). Patient and control groups were selected from the 16,000-patient ARIC (Atherosclerosis Risk in Communities) trial.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT070707

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel